Signaling pathways
-
BA2763 DinoprostSummary: Dinoprost (ProstaglandinF2α) is an orally effective prostaglandin F (PGF) receptor agonist. - BA2764 MGH-CP1Summary: MGH-CP1 is a potent and orally active and self-palmitoylation inhibitor at 710 nM and 672 nM, respectively.
-
BA2766 MYCMI-6Summary: MYCMI-6 (NSC354961) is a potent and selective inhibitor of endogenous protein interactions. - BA2767 COG1410Summary: COG1410 is an apolipoprotein E-derived peptide and apoptosis inhibitor.
- BA2768 Amiloride1 CitationSummary: Amiloride (MK-870) is an inhibitor of epithelial sodium channels and urokinase-type fibrinogen activator receptors.
- BA2769 MS1943Summary: MS1943 is a first-of-its-kind, orally bioactive, selective degradant.
- BA2770 MivebresibSummary: Mivebresib (ABBV-075) is an effective.
-
BA2771 DCZ0415Summary: DCZ0415 is a potent inhibitor that impairs non-homologous end-joining repair and inhibits activity. - BA2772 FluorizolineSummary: Fluorizoline selectively binds directly to prohibitin 1 and 2 and induces apoptosis.
- BA2773 GSK778Summary: GSK778 (iBET-BD1) is a potent and selective inhibitor of the bromodomain of the protein.